Global In-vitro Toxicology Assays Market for Cannabis and Nicotine Testing Report 2021 - Forecasts to 2028 - Featuring Key Major Players

News provided by

Oct 26, 2021, 06:45 ET

DUBLIN, Oct. 26, 2021 /PRNewswire/ -- The "In-vitro Toxicology Assays Market For Cannabis and Nicotine Testing Size, Share & Trends Analysis Report By Test Type, By Technology, By Application (Cytotoxicity Testing, Genetic Toxicity Testing), By Method, By Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global in-vitro toxicology assays market size for cannabis and nicotine testing is expected to reach USD 2.9 billion by 2028. The market is expected to expand at a CAGR of 11.2% from 2021 to 2028. Growing adoption of high throughput techniques in cannabis testing, legalization of medical cannabis, and growing awareness regarding the potential hazards of nicotine consumption have majorly driven the market throughout the forecast period.

The legalization of medical cannabis is underway globally, including in countries such as Germany, Australia, and Israel. The market is gaining momentum in the Asia Pacific region, with Thailand having fully legalized medicinal cannabis. Thus, increasing legalization of medical cannabis is expected to drive the market growth to a major extend. In addition, technological advancements in cellular assays have boosted market growth.

COVID-19 has become a catalyst for changing the traditional use of cannabis. Owing to the pandemic, the leading scientific community and market competitors are now focusing on deciphering the potential of cannabis to prevent SARS-CoV-2 infection. Companies have reported the increase in the sale of cannabis as some states/countries have declared cannabis as an essential medicine during the pandemic.

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Report Highlights

Nicotine testing accounted for the largest revenue in 2020 and is expected to continue the trend in the forecast period owing to increasing safety concerns associated with nicotine products.
Cannabis testing is expected to witness gradual growth through 2021-2028 owing to the rising acceptance of cannabis for medical use.
3D cell culture technology is expected to grow at substantial CAGR owing to the increasing popularity of drug development and toxicity testing.
Cytotoxicity testing design accounted for the highest market revenue in 2020 owing to advancements in different tools for evaluating the cytotoxic effects of nicotine-containing products.
North America has emerged as the highest revenue-generating region in 2020, owing to the prevalence of cancer, presence of key players, and developed healthcare infrastructure.
Asia Pacific is anticipated to witness the fastest CAGR throughout the forecast period. It is anticipated that China and India are contributing majorly to the regional market's growth.
Key players are undertaking various strategic initiatives such as mergers and acquisitions to maintain their presence in the market.
In August 2020, Eurofins Scientific purchased approximately 136 smaller labs within 3 years from 2014 to 2019, accounting for a total expenditure of USD 3.4 billion in these acquisitions.

Companies Mentioned:

Stemina Biomarker Discovery, Inc.
Broughton Nicotine Services
Labstat International, Inc.
Iontox
Toxikon
Integrated Laboratory Systems
Enthalpy Analytical (Enthalpy)
Pbr Laboratories, Inc.

Key Topics Covered:

Chapter 1 Methodology and Scope
1.1 Research Assumptions
1.2 Research Methodology
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.5 Information or Data Analysis
1.6 Market Formulation And Validation
1.7 Market Model
1.7.1 Model Details
1.7.2 Revenue Share Assessment Of Technology Scope
1.8 Objectives

Chapter 2 Executive Summary
2.1 Market Summary, 2020
2.2 Market Segmentation

Chapter 3 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 COVID-19 Impact Analysis: In vitro Toxicology Assays Market for Cannabis and Nicotine Testing
3.4 In Vitro Toxicology Assay Market for Cannabis and Nicotine Testing: Market Analysis Tools
3.5 Penetration and Growth Prospect Mapping for Test Type, 2020

Chapter 4 Competitive Landscape
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Private Companies
4.4 Stakeholders Landscape
4.5 Major Deals & Strategic Alliances Analysis
4.6 Regional Network Map

Chapter 5 In Vitro Toxicology Assay Market For Cannabis and Nicotine Testing: Test Type Business Analysis
5.1 In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Test Type Movement Analysis
5.2 Cannabis Testing
5.2.1 In Vitro Toxicology Market For Cannabis Testing, 2017 - 2028 (USD Million)
5.3 Nicotine Testing
5.3.1 In vitro toxicology market for nicotine testing, 2017 - 2028 (USD MILLION)

Chapter 6 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Method Business Analysis
6.1 Global In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Method Movement Analysis
6.2 Cellular Assay
6.2.1 Cellular Assay-Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 - 2028 (USD Million)
6.3 Others
6.3.1 Other Assay-Based In Vitro Toxicology Market For Cannabis & Nicotine Testing, 2017 - 2028 (USD Million)

Chapter 7 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Technology Business Analysis
7.1 In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Technology Movement Analysis
7.2 3D Cell Culture Technology
7.2.1 3D Cell Culture Technology For In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)
7.3 Mass Spectrometry
7.3.1 Mass Spectrometry Technology For In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)
7.4 Flow Cytometry
7.4.1 Flow Cytometry Technology For In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)
7.5 Others
7.5.1 Other Technologies For In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)

Chapter 8 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Application Business Analysis
8.1 In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Application Movement Analysis
8.2 Genetic Toxicity Testing
8.2.1 Gene Toxicity Testing Application Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)
8.3 Carcinogenicity Testing
8.3.1 Carcinogenicity Testing Application Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)
8.4 Cytotoxicity Testing
8.4.1 Cytotoxicity Testing Application Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)
8.5 Mutagenicity Testing
8.5.1 Mutagenicity Testing Application Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)
8.6 Other Applications
8.6.1 Other Applications Of In Vitro Toxicology Assays Market For Nicotine & Cannabis Testing, 2017 - 2028 (USD Million)

Chapter 9 In Vitro Toxicology Assay Market For Cannabis And Nicotine Testing: Regional Business Analysis
9.1 In Vitro Toxicology Assays Market For Cannabis And Nicotine Testing: Regional Movement Analysis
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Singapore
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East And Africa
9.6.1 South Africa
9.6.2 Saudi Arabia